These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22126887)

  • 21. [KYRLE'S DISEASE].
    HOFFMANN-MARTINOT
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():760-1. PubMed ID: 14271162
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [KYRLE'S DISEASE: SOME ETIOPATHOGENETIC DATA ON A CLINICAL CASE].
    BINAZZI M; SCERRATO R
    Rass Dermatol Sifilogr; 1963; 16():113-24. PubMed ID: 14053779
    [No Abstract]   [Full Text] [Related]  

  • 24. Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?
    Hajjar RJ; Leopold JA
    Circ Res; 2006 Feb; 98(2):169-71. PubMed ID: 16456108
    [No Abstract]   [Full Text] [Related]  

  • 25. Allopurinol induced meningitis.
    Duchene DA; Smith CP; Goldfarb RA
    J Urol; 2000 Dec; 164(6):2028. PubMed ID: 11061913
    [No Abstract]   [Full Text] [Related]  

  • 26. A case for diagnosis: (Porokeratosis? Kyrle's disease?).
    LEAVELL UW; STEWART JJ; THOMSEN JG; COLE HN; DRIVER JR
    Arch Derm Syphilol; 1950 May; 61(5):879-80. PubMed ID: 15411244
    [No Abstract]   [Full Text] [Related]  

  • 27. HYPERKERATOSIS PENETRANS (KYRLE'S DISEASE).
    PETERSON WC; GOLTZ RW; HULT AM
    Arch Dermatol; 1963 Aug; 88():210-4. PubMed ID: 14043612
    [No Abstract]   [Full Text] [Related]  

  • 28. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
    Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperkeratosis follicularis et parafollicularis in cutem penetrans (Kyrle's disease)].
    GRANA A
    G Ital Dermatol; 1955; 96(2):125-41. PubMed ID: 13241782
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of Kyrle's disease ("hyperkeratosis follicularis" and "parafollicularis in cutem penertrans")].
    AUPAIX M; LELOUP R
    Bull Soc Fr Dermatol Syphiligr; 1959; 5():808-11. PubMed ID: 13795141
    [No Abstract]   [Full Text] [Related]  

  • 31. Squamous cell carcinoma developed on Kyrle's disease scar.
    Rallis E; Stavropoulos PG; Papafragkaki DK; Katsarou-Katsari A; Avgerinou G
    J BUON; 2014; 19(1):317-8. PubMed ID: 24659683
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy.
    Stull LB; Leppo MK; Szweda L; Gao WD; Marbán E
    Circ Res; 2004 Nov; 95(10):1005-11. PubMed ID: 15499028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy: Xanthine oxidase inhibition for relief of angina pectoris.
    de Silva R; Fox KM
    Nat Rev Cardiol; 2010 Nov; 7(11):603-4. PubMed ID: 20975655
    [No Abstract]   [Full Text] [Related]  

  • 34. [KYRLE'S "HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS IN CUTEM PENETRANS"].
    MARAGNANI U
    Minerva Dermatol; 1963 Oct; 38():318-23. PubMed ID: 14098397
    [No Abstract]   [Full Text] [Related]  

  • 35. [Secondary hyperuricemia in hematologic disease].
    Inai K; Tsutani H
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():299-303. PubMed ID: 12629735
    [No Abstract]   [Full Text] [Related]  

  • 36. [DISSEMINATED HYPERKERATOSIS. KYRLE'S DISEASE?].
    HADIDA E; TRAMIER G; SAYAG J; COULIER L
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():82-3. PubMed ID: 14184750
    [No Abstract]   [Full Text] [Related]  

  • 37. [Kyrle's palmoplantar disease. Role of arsenic in its etiology].
    BAZEX A; DUPRE ; PARANT
    Arch Belg Dermatol Syphiligr; 1961 Jan; 17():41-6. PubMed ID: 14448525
    [No Abstract]   [Full Text] [Related]  

  • 38. Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio.
    Gardiner SJ; Gearry RB; Burt MJ; Chalmers-Watson T; Chapman BA; Ross AG; Stedman CA; Huelsen A; Barclay ML
    J Gastroenterol Hepatol; 2011 Jan; 26(1):49-54. PubMed ID: 21175793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperkeratosis penetrans (Kyrle's disease). Report of a case in a Negro with autopsy findings.
    ABELE DC; DOBSON RL
    Arch Dermatol; 1961 Feb; 83():277-83. PubMed ID: 13680983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.